4F-MDMB-BINACA

4F-MDMB-BINACA (also known as 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.[1] It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug. 4F-MDMB-BINACA is an agonist of the CB1 receptor, though it is unclear whether it is selective for this target.[2] In December 2019, the UNODC announced scheduling recommendations placing 4F-MDMB-BINACA into Schedule II.[3]

4F-MDMB-BINACA

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act
Identifiers
IUPAC name Methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate
PubChem CID	145707216
ChemSpider	71117201
Chemical and physical data
Formula	C19H26FN3O3
Molar mass	363.433 g·mol^−1
3D model (JSmol)	Interactive image
SMILES O=C(N[C@H](C(OC)=O)C(C)(C)C)C1=NN(CCCCF)C2=C1C=CC=C2
InChI InChI=1S/C19H26FN3O3/c1-19(2,3)16(18(25)26-4)21-17(24)15-13-9-5-6-10-14(13)23(22-15)12-8-7-11-20/h5-6,9-10,16H,7-8,11-12H2,1-4H3,(H,21,24)/t16-/m1/s1 Key:GZGKSDAMWRWYOZ-MRXNPFEDSA-N

See also

• 5F-MDMB-PINACA
• 5F-MDMB-PICA
• 5F-MMB-PINACA
• AB-FUBINACA

References

1. Krotulski, Alex J.; Mohr, Amanda L. A.; Kacinko, Sherri L.; Fogarty, Melissa F.; Shuda, Sarah A.; Diamond, Francis X.; Kinney, William A.; Menendez, M. J.; Logan, Barry K. (September 2019). "4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework". Journal of Forensic Sciences. 64 (5): 1451–1461. doi:10.1111/1556-4029.14101. ISSN 1556-4029. PMID 31260580.
2. "4F-MDMB-BINACA(4F-MDMB-BUTINACA)" (PDF).
3. "December 2019 – WHO: World Health Organization recommends 12 NPS for scheduling".